Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
NDRC Solicits Comments on Drug Price Reform Plan (With Thorough Summary)
Following rounds of confidential discussions within the NDRC and its local agencies, the agency released a draft document, Plan for Advancing Drug Pricing Reform (Draft),... (11/27/2014)
   
China Issues Draft Guidance On Multi-Regional Clinical Trials (11/27/2014)
NDRC's Ill-fated Drug Price Reform Path and Latest Proposal to Exit (11/27/2014)
American Biotech Start-Ups Head To China For Capital Partners (External) (11/25/2014)
Chinese Pharma to Grow Slower Amid Uncertainties and Proposed Liberalizations (11/24/2014)
China Telemedicine: How it Might Reshape Pharmacies (11/23/2014)
An Unexpected Reality in the Post-GSK World (11/20/2014)
China Healthcare Multi Channel Marketing? OK, But Where? (11/19/2014)
China Healthcare Advertising: Failure to Learn (11/19/2014)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in Q3/2014 (11/14/2014)
China Solicits Comments On Biosimilars Guideline (11/6/2014)
China Aims To Tighten Supervision Over Clinical Studies (11/4/2014)
Several Issues In Foreign Investor's Acquisition Of Chinese Pharmaceutical Enterprises (11/4/2014)
An In-Depth Look At The New China Trademark Law (11/4/2014)
China Economic Net: The Chinese Pharmas Market (10/23/2014)
Official Arrests Interrupt Drug Price Reform as Chinese Pharma Growth Continues (10/23/2014)
Financial-related Company News in Brief  (11/28/2014)
Data Snapshot: China Saw Over 200 New FI...  (11/27/2014)
Data Snapshot – Hospital Consumption of...  (11/27/2014)
Improving Access to Medicine in Developi...  (11/27/2014)
Tanabe Mitsubishi Pharma Sells Guangzhou...  (11/27/2014)
NDRC Solicits Comments on Drug Price Ref...  (11/27/2014)
Recent Executive Moves  (11/26/2014)
2014 China Mobile Health Report Finds Po...  (11/26/2014)
Alzheimer's Disease and Dementia Keep Ri...  (11/25/2014)
2014 The Most Active Year for Healthcare...  (11/25/2014)
Central Government to Inspect County Lev...  (11/25/2014)
NEJM, PKU Join Hands to Advance Clinical...  (11/25/2014)
BMS China Cuts Headcount of Medical Repr...  (11/25/2014)
Liaoning Implements Hospital Essential D...  (11/24/2014)
International Coalition of Medicines Reg...  (11/24/2014)
Improving Access to Medicine in Developing Countries
2014 The Most Active Year for Healthcare Deals in Two De...
CSDD: Cost to Develop A New Drug Now Exceeds US$2.5B
M&A, Licensing Abound - Global Pharma Industry Outlo...
Actavis to Acquire Allergan for US$66B
Data Snapshot – Hospital Consumption of Anti-cholesterol Drugs...
Chinese Clinical Research Market to Exceed CNY 40 Billion
Data Snapshot - Hospital Anti-infective Drug Consumption in Yan...
New Report: Chinese Insulin Market Driven by Increased Diabetes...
New Report: Chinese Recombinant Protein Drug Sales Projected to...
Financial-related Company News in Brief
Data Snapshot: China Saw Over 200 New FIEs in the Pharma Sec...
Tanabe Mitsubishi Pharma Sells Guangzhou Subsidiary to Shuai...
NEJM, PKU Join Hands to Advance Clinical and Translational M...
BMS China Cuts Headcount of Medical Representatives
NDRC Solicits Comments on Drug Price Reform Plan (With T...
International Coalition of Medicines Regulatory Authorit...
CFDA and USFDA Sign Agreement for Exchange of Regulatory...
CFDA Issues the Third Supplements to the Chinese Pharmac...
CFDA Ministers Met Heads of Top Foreign Drug Regulators
China Issues Legal Interpretations for Criminal Cases Involv...
NHFPC to Expedite the Basic Medical and Health Legislation P...
Chinese Court Imposes CNY 3 Bln Record Fine on GSK for Bribe...
US Anti-bribery Probe Expands to GSK Consumer Healthcare Bus...
Chinese Advertisement Law Amendment to Heighten Requirements...
Lonza to Manufacture Sunshine Biopharma's Novel Anticanc...
Baiyunshan, Alkpharm to Join Hands for API Manufacturing...
UniTao Pharma Buys Boehringer Ingelheim's API Facility i...
India Depends On China for 90% of Its Key APIs and Inter...
Chinese Heparin API Market to Account Roughly 80% of Glo...
China Inaugurates National Center for Translational Medi...
SIMM Scientists Discover Novel Anti-coagulant Drug Candi...
SIMM Develops Novel Drug Candidate for B Cell Acute Lymp...
Chinese Scientists Discover Alphavirus with Antitumor Ac...
Sihuan Buys Rights of Ebola Drug from AMMS UNIT
2014 China Mobile Health Report Finds Positive Growth Pr...
Alzheimer's Disease and Dementia Keep Rising in China As...
Central Government to Inspect County Level Hospital Refo...
Liaoning Implements Hospital Essential Drug Consumption ...
Guangdong Conducts Undercover Investigations of Physicia...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Pharma & Biotech Billionaires Represent 15% of 2014 Fo...
Upcoming Event: Biotech China 2015
Upcoming Event: Annual Biologics World Taiwan 2015
Upcoming Event: Executive Etiquette Excellence Seminar b...
Upcoming Event: Executive Etiquette Excellence Seminar b...
Upcoming Event: Executive Etiquette Excellence Seminar b...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
  Pharma China adds one more dis...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links